Aldosterone antagonism in diastolic heart failure.

Trial Profile

Aldosterone antagonism in diastolic heart failure.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2011

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Sep 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 03 Jun 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top